Lumida
/DHI
⌘K
DR Horton Inc

DR Horton Inc

DHI
$137.89USD+1.71%+2.32 today

MARKET CAP

38.6B

P/E (TTM)

12.9x

FWD P/E

DAY RANGE

$135 – $139

52W RANGE

$132
$181

AI Summary

Stalk
TrimMedium

DHI remains in a Stage 4 declining phase with clear lower highs and lower lows under its declining EMAs, confirming the downtrend. Price trades below the EMA9/20/50 cluster after breaking near-term support and is near extreme oversold, but no convincing relief bounce or reclaim has emerged. Medium-term bias is bearish and execution is best deferred; look for a rally into the 140–144 EMA/SMA zone for bearish exposure via rejection at overhead resistance.

  • Q3 closings at 23,983 homes with 13.3% margin and EPS of $3.20
  • Paid $127M dividends and repurchased $616M of stock, yielding 0.53%
  • Revenue expected down >9% YoY in FY26; Q3 held flat at $9.2B
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$27.8B$33.5B$35.5B$36.8B$34.3B
YoY %+36.7%+20.5%+5.9%+3.8%-6.9%
P / Sales1.1x0.7x1.0x1.7x1.5x
EV / Sales1.3x1.0x1.2x1.9x1.8x
Gross Profit, Adj.$7.9B$10.5B$9.4B$9.5B$8.1B
YoY %+59.5%+33.4%-11.0%+2.0%-14.9%
Margin %28.4%31.4%26.4%25.9%23.7%
EV / Gross Profit4.6x3.0x4.5x7.2x7.4x
EBITDA, Adj.$5.4B$7.7B$6.2B$6.0B$4.5B
YoY %+81.2%+41.7%-19.1%-2.7%-24.9%
Margin %19.4%22.9%17.5%16.4%13.2%
EV / EBITDA6.7x4.2x6.8x11.5x13.3x
EBIT$5.3B$7.6B$6.1B$5.9B$4.4B
YoY %+84.0%+42.3%-19.4%-2.7%-25.5%
Margin %19.2%22.6%17.2%16.1%12.9%
EV / EBIT6.8x4.2x6.9x11.6x13.6x
Net Income$4.2B$5.9B$4.7B$4.8B$3.6B
YoY %+75.9%+40.3%-19.0%+0.2%-24.6%
Net Margin15.0%17.5%13.4%12.9%10.5%
EPS (GAAP)$11.41$16.51$13.82$14.34$11.57
YoY %+78.0%+44.7%-16.3%+3.8%-19.3%